[1]BulletindelaSocieteChimiquedeFrance,1954,p.1048,1052
[2]Patent:US2009/143448,2009,A1
[1]Patent:US2009/143448,2009,A1
[1]ACSMedicinalChemistryLetters,2021,vol.12,p.129-135
1955514-54-1 | oxalic acid, tert-butyl 1,7-diazaspiro[3.5]nonane-1-carboxylate | AA01C3SG | MFCD28992042
682339-44-2 | 5-nitro-2-[(oxiran-2-yl)methoxy]phenol | AA01C3WZ | MFCD29906860
1909308-98-0 | 1-(2-bromo-4-methylphenyl)cyclohexan-1-amine hydrochloride | AA01C41U | MFCD29763004
1909305-55-0 | 2,6-dimethylmorpholine-3-carboxylic acid hydrochloride | AA01C46B | MFCD29763059
1784133-02-3 | 2-(3-hydroxypiperidin-3-yl)acetamide | AA01C4B1 | MFCD28649993
2031242-23-4 | rac-(2R,3R)-2-(1-phenyl-1H-pyrazol-5-yl)oxolan-3-amine hydrochloride, trans | AA01C4F2 | MFCD29065871
6628-19-9 | 2-(2,4-Dihydroxythiazol-5-yl)acetic acid | AA01C4KI | MFCD00022448
29671-77-0 | 3,3-dichloroprop-2-ene-1-sulfonamide | AA01C4PJ | MFCD30344811
1824685-77-9 | tert-butyl N-[4-(ethoxysulfonyl)but-3-en-2-yl]carbamate | AA01C4UV | MFCD24542110
1909326-63-1 | tert-butyl 5-amino-1-methyl-1h-pyrazole-4-carboxylate | AA01C504 | MFCD29907054